| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.046 | 0.4 |